Showing results (1-10 of 3,381) with videos related to

Sort By:
Pageof 339
Zhongguo Shi Yan Xue Ye Xue Za Zhi|November 3, 2015
[Relationship between Chemotactic Factor CCL5 and Diabet-associated Diffuse Large B Cell Lymphoma]Jing-Cheng Zhang, Fan-Rong Liu, Hui-Xian Hu, et al.
Frontiers in Medicine|March 20, 2023
Related donor platelet transfusion improves platelet transfusion refractoriness in hematological patientsJing-Cheng Zhang, Li-Hong Ni, Yan Tu, et al.
Oncology Letters|February 14, 2018
The association between differentially expressed micro RNAs in breast cancer cell lines and the micro RNA-205 gene polymorphism in breast cancer tissueJingcheng Zhang, Bin Wei, Huixian Hu, et al.
Hematological Oncology|September 7, 2024
Research on the mechanism of HOPX-HDAC2 interaction inducing differentiation blockage in acute myeloid leukemiaFang He, Yan Tu, Lihong Ni
HLA|January 9, 2022
The novel HLA-DRB1*13:306 allele, identified by sequencing-based typing in a Chinese individualFang He, Zhong-Zheng Zheng, Lin An, et al.
Hematology (Amsterdam, Netherlands)|April 16, 2024
Nomogram establishment for short-term survival prediction in ICU patients with aplastic anemia based on the MIMIC-IV databaseYan Tu, Jingcheng Zhang, Mingzhe Zhao, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|June 23, 2026
Zanubrutinib, Lenalidomide, and Rituximab Demonstrate Efficacy in Relapsed/Refractory Central Nervous System Lymphoma: A Single - Center Retrospective StudyJingcheng Zhang, Fang He, Yan Tu, et al.
Journal of Cancer Research and Clinical Oncology|September 19, 2024
Imatinib mesylate reduces c-MYC expression in double-hit lymphoma cells by suppressing inducible cytidine deaminaseJingCheng Zhang, Sheng Zhou, SiSi Jiang, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|June 29, 2012
[Clinical significance of serum lactate dehydrogenase, β2-microglobulin and vascular endothelial growth factor level detection in patients with non-Hodgkin's lymphoma]Yong Duan, Ge Li, Hui-Xian Hu
Oncology Letters|August 10, 2017
Preliminary study on decreasing the expression of FOXP3 with miR-155 to inhibit diffuse large B-cell lymphomaJincheng Zhang, Bin Wei, Huixian Hu, et al.
Pageof 339